Immunoprecise Antibodies Ltd (IPA) — Financial Flexibility Index
Immunoprecise Antibodies Ltd (IPA) has a Financial Flexibility Index of -0.04x as of April 2025. Free cash flow of $-781.00K (operating CF $-1.14 Million minus capex $359.00K) represents 0% of total liabilities ($20.82 Million). Also explore how fast is Immunoprecise Antibodies Ltd growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immunoprecise Antibodies Ltd Financial Flexibility Index (1997–2025)
Historical Financial Flexibility Index trend for Immunoprecise Antibodies Ltd across 29 annual periods. Check IPA PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Immunoprecise Antibodies Ltd (1997–2025)
Year-by-year free cash flow to debt coverage for Immunoprecise Antibodies Ltd. For the full company profile including market capitalisation, see IPA market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.27x | $-5.61 Million | $-6.41 Million | $20.82 Million | ▼ -146.6% |
| 2024 | -0.11x | $-2.85 Million | $-4.25 Million | $26.07 Million | ▲ +88.1% |
| 2023 | -0.92x | $-18.34 Million | $-19.83 Million | $20.01 Million | ▼ -92.6% |
| 2022 | -0.48x | $-8.66 Million | $-9.92 Million | $18.21 Million | ▼ -677.4% |
| 2021 | 0.08x | $827.00K | $-600.00K | $10.04 Million | ▲ +223.0% |
| 2020 | -0.07x | $-815.65K | $-1.39 Million | $12.18 Million | ▲ +73.1% |
| 2019 | -0.25x | $-2.56 Million | $-3.21 Million | $10.28 Million | ▲ +3.6% |
| 2018 | -0.26x | $-3.07 Million | $-3.42 Million | $11.87 Million | ▼ -13.4% |
| 2017 | -0.23x | $-190.90K | $-721.65K | $836.91K | ▼ -135.7% |
| 2016 | 0.64x | $301.57K | $284.09K | $472.15K | ▲ +1130.0% |
| 2015 | -0.06x | $-15.79K | $-36.11K | $254.64K | ▲ +59.6% |
| 2014 | -0.15x | $-46.60K | $-46.60K | $303.50K | ▼ -840.9% |
| 2013 | -0.02x | $-4.33K | $-4.33K | $265.63K | ▲ +97.3% |
| 2012 | -0.62x | $-131.08K | $-132.72K | $213.10K | ▼ -1.6% |
| 2011 | -0.61x | $-66.73K | $-80.39K | $110.21K | ▼ -513.9% |
| 2010 | 0.15x | $14.32K | $-308.49K | $97.87K | ▼ -98.2% |
| 2009 | 8.18x | $1.23 Million | $-155.68K | $150.84K | ▲ +173.2% |
| 2008 | -11.17x | $-418.41K | $-523.45K | $37.46K | ▼ -402.6% |
| 2007 | 3.69x | $1.53 Million | $-297.31K | $413.69K | ▼ -70.5% |
| 2006 | 12.53x | $1.74 Million | $-110.59K | $138.62K | ▼ -24.0% |
| 2005 | 16.48x | $777.57K | $-82.20K | $47.18K | ▲ +957.4% |
| 2004 | 1.56x | $77.81K | $-178.69K | $49.92K | ▲ +342.9% |
| 2003 | -0.64x | $-18.95K | $-168.38K | $29.53K | ▲ +55.6% |
| 2002 | -1.45x | $-271.35K | $-280.23K | $187.72K | ▼ -287.2% |
| 2001 | 0.77x | $692.26K | $-8.13K | $896.75K | ▲ +114.4% |
| 2000 | -5.37x | $-54.30K | $-208.54K | $10.11K | ▼ -217.0% |
| 1999 | 4.59x | $164.24K | $-202.94K | $35.78K | ▼ -63.7% |
| 1998 | 12.65x | $852.70K | $-226.81K | $67.39K | ▲ +668.4% |
| 1997 | 1.65x | $411.71K | $-108.20K | $250.04K | — |